Gross Profit - Newron Pharmaceuticals SpA (SIX:NWRN) - Alpha Spread

Newron Pharmaceuticals SpA
SIX:NWRN

Watchlist Manager
Newron Pharmaceuticals SpA Logo
Newron Pharmaceuticals SpA
SIX:NWRN
Watchlist
Price: 7.66 CHF -3.04%
Market Cap: 145.9m CHF
Have any thoughts about
Newron Pharmaceuticals SpA?
Write Note

Newron Pharmaceuticals SpA
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Newron Pharmaceuticals SpA
Gross Profit Peer Comparison

Comparables:
REC
P
PRL
FCM
SHE

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Newron Pharmaceuticals SpA
SIX:NWRN
Gross Profit
€8.6m
CAGR 3-Years
20%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Gross Profit
€1.5B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
9%
P
Pierrel SpA
MIL:PRL
Gross Profit
€23.2m
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
-4%
Friulchem SpA
MIL:FCM
Gross Profit
€4.8m
CAGR 3-Years
24%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Shedir Pharma Srl Unipersonale
MIL:SHE
Gross Profit
€35.8m
CAGR 3-Years
12%
CAGR 5-Years
3%
CAGR 10-Years
N/A

See Also

What is Newron Pharmaceuticals SpA's Gross Profit?
Gross Profit
8.6m EUR

Based on the financial report for Dec 31, 2023, Newron Pharmaceuticals SpA's Gross Profit amounts to 8.6m EUR.

What is Newron Pharmaceuticals SpA's Gross Profit growth rate?
Gross Profit CAGR 5Y
26%

Over the last year, the Gross Profit growth was 52%. The average annual Gross Profit growth rates for Newron Pharmaceuticals SpA have been 20% over the past three years , 26% over the past five years .

Back to Top